December 8, 2020
Limping to the finish
2020 may be known for Covid, the Presidential election and a very bad Chicago Bears football team (sorry had to throw that in as losing to the Packers is one thing but the Lions geez) it will also be known for a pretty good year for diabetes related stocks. Dexcom, Tandem and Insulet the Three Amigos and almost pure diabetes plays are doing quite nicely. Novo Nordisk has done ok as has Lilly nothing great but better than Medtronic which is treading water this year. It should come as no surprise that Teladoc is having a great year.
Yet . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
